Monday, February 24, 2025 | 10:11 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Metropolis Healthcare

Metropolis Healthcare shares gain 4% on posting Q3 results; PAT up 15 YoY

The company in the quarter ended December 31, 2024, reported a 15.3 per cent rise in consolidated net profit to Rs 31 crore as compared to Rs 27 crore a year ago

Metropolis Healthcare shares gain 4% on posting Q3 results; PAT up 15 YoY
Updated On : 05 Feb 2025 | 11:33 AM IST

Metropolis Healthcare Q3 results: Net profit soars 15%, revenue up 10.8%

On a sequential basis, the company's revenue declined by 7.7 per cent, while PAT also fell by 32.5 per cent

Metropolis Healthcare Q3 results: Net profit soars 15%, revenue up 10.8%
Updated On : 04 Feb 2025 | 9:18 PM IST

Metropolis Healthcare, Roche team up to launch HPV DNA testing in India

"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said

Metropolis Healthcare, Roche team up to launch HPV DNA testing in India
Updated On : 03 Feb 2025 | 8:19 PM IST

Stocks to sell on rise: Apollo Tyres, Cyient may fall upto 34%, show charts

Metropolis Healthcare, Alembic Pharma and Tejas Networks are the other 3 stocks to witness a 'Death Cross' on the chart in recent days; technically this is a negative development for these stocks.

Stocks to sell on rise: Apollo Tyres, Cyient may fall upto 34%, show charts
Updated On : 31 Jan 2025 | 1:00 PM IST

Chose growth over profitability: Core Diagnostics' Zoya on acquisition

India has several venture-backed startups for whom the natural consequence is to have an exit, and between profitability and growth in the journey ahead, "we opted for the latter", Zoya Brar, founder of Core Diagnostics, which was recently acquired by Metropolis Healthcare, said. Metropolis Healthcare, one of India's leading diagnostics chains, acquired specialised diagnostics company Core Diagnostics for Rs 246.8 crore last month. "For an organisation to scale, it can either do it organically or inorganically. Since we have a number of venture-backed startups (in India), the natural consequence is, there needs to be an exit. And while IPOs are an option, they need a certain volume and scale before it makes sense. So we will continue to see consolidation," Brar told PTI. "Most importantly, incumbents like Metropolis need to constantly differentiate themselves to remain ahead of the competitive landscape and one simple way to do that is to acquire insurgents that have built an ...

Chose growth over profitability: Core Diagnostics' Zoya on acquisition
Updated On : 07 Jan 2025 | 10:52 AM IST

F&O Market: Union Bank, Dabur see short build-up as Nifty tumbles 300pts

Union Bank stock futures plunged nearly 8% on the back of 54% increase in OI. On the other hand, Dr. Lal Path Labs and Metropolis Health witnessed long build-up on Monday; shows derivatives data.

F&O Market: Union Bank, Dabur see short build-up as Nifty tumbles 300pts
Updated On : 06 Jan 2025 | 12:50 PM IST

Core acquisition adds to Metropolis Healthcare's long-term growth plans

Market share gains in the B2C portfolio are visible and Tier III+ markets are likely to contribute to the patient volume growth guidance

Core acquisition adds to Metropolis Healthcare's long-term growth plans
Updated On : 19 Dec 2024 | 11:33 PM IST

Axis Bank, Nippon AMC, Maruti: JM Financial picks 12 stocks to buy for 2025

From the robust banking and financial services domain, Axis Bank and Nippon AMC make the cut. The auto industry sees Maruti Suzuki and Samvardhana Motherson International (SAMIL) in the spotlight

Axis Bank, Nippon AMC, Maruti: JM Financial picks 12 stocks to buy for 2025
Updated On : 11 Dec 2024 | 9:24 AM IST

Metropolis Healthcare shares rise 3% after acquiring Core Diagnostics

Shares of diagnostic firm Metropolis Healthcare surged 2.88 per cent at Rs 2,250 per share on the BSE in Tuesday's intraday trade

Metropolis Healthcare shares rise 3% after acquiring Core Diagnostics
Updated On : 10 Dec 2024 | 11:21 AM IST

Stocks to Watch on Dec 10: Vi, Metropolis, MapmyIndia, TaMo, LIC, PFC

Stocks to Watch on Dec 10: From Vodafone Idea (Vi) to Tata Motors, here is a list of stocks that will remain in limelight today

Stocks to Watch on Dec 10: Vi, Metropolis, MapmyIndia, TaMo, LIC, PFC
Updated On : 10 Dec 2024 | 7:47 AM IST

Metropolis Healthcare adds Core strength to specialty cancer diagnostics

Buys 100% stake in Core Diagnostics through cash, stock for Rs 247 crore

Metropolis Healthcare adds Core strength to specialty cancer diagnostics
Updated On : 09 Dec 2024 | 11:24 PM IST

Metropolis Healthcare to acquire Core Diagnostics for Rs 247 crore

Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from its existing shareholder Core Diagnostics (Mauritius) Pvt Ltd, Metropolis Healthcare said in a regulatory filing. Pursuant to the completion of acquisition, Core Diagnostics will become a wholly owned subsidiary of the company, it added. "This strategic acquisition will enhance Metropolis Healthcare's advanced cancer testing capabilities and strengthen its footprint in northern and eastern India," the diagnostic chain said. By leveraging Core Diagnostics' strong relationships with leading cancer specialists and hospitals in these regions, Metropolis aims to expand its market reach and specialised testing offerings, it added. "With approximately 1.4 million new cancer cases and nearly a million deaths annually in India, there is a critical need for advanced cancer testing nationwide.

Metropolis Healthcare to acquire Core Diagnostics for Rs 247 crore
Updated On : 09 Dec 2024 | 6:43 PM IST

Metropolis Healthcare plans to expand reach to 1,000 towns in 18 months

The firm aims to strengthen its presence in tier 2 and tier 3 cities, supported by an investment of approximately Rs 65 crore

Metropolis Healthcare plans to expand reach to 1,000 towns in 18 months
Updated On : 12 Nov 2024 | 7:51 PM IST

Indian population saw 30% increase in ANAs post Covid-19, says study

ANAs are proteins produced by the immune system that mistakenly target the body's own cells, leading to tissue damage and autoimmune diseases like rheumatoid arthritis and thyroid disorders

Indian population saw 30% increase in ANAs post Covid-19, says study
Updated On : 22 Oct 2024 | 5:55 PM IST

Not looking to bring any strategic investor on board now: Ameera Shah

In a video interview with Sohini Das, Shah outlines her plans for international business, and also why she got in a new CEO

Not looking to bring any strategic investor on board now: Ameera Shah
Updated On : 14 Aug 2024 | 8:27 PM IST

Patient influx, test volumes raise Metropolis Healthcare's profit by 31%

Commenting on the results, Ameera Shah, Executive Chairperson and Whole-time Director, Metropolis Healthcare, said that the company has consistently achieved high growth in patient volume

Patient influx, test volumes raise Metropolis Healthcare's profit by 31%
Updated On : 11 Aug 2024 | 1:21 PM IST

5 stocks with long buildup: AU SFB, Marico, TVS Motor may surge up to 22%

Aditya Birla Fashion, AU Small Finance Bank, Metropolis, Marico and TVS Motor have seen steady rise in stock price, backed by rise in open interest, thus indicating long buildup at these counters in t

5 stocks with long buildup: AU SFB, Marico, TVS Motor may surge up to 22%
Updated On : 07 Jun 2024 | 10:17 AM IST

Metropolis Health up 8% post Q4 nos; Ameera appointed Executive Chairperson

Metropolis Health stock update: Metropolis Healthcare stock price hit a fresh record high of Rs 2,049 on Wednesday. Ameera Shah takes charge as executive chairperson and whole-time director

Metropolis Health up 8% post Q4 nos; Ameera appointed Executive Chairperson
Updated On : 22 May 2024 | 2:23 PM IST

RIL, Sun Pharma, HDFC Bank, BHEL among 11 stocks to monitor on May 22

At 7:09 AM, GIFT Nifty futures indicated a modest uptick of 25 points, trading at 22,626 against Nifty futures

RIL, Sun Pharma, HDFC Bank, BHEL among 11 stocks to monitor on May 22
Updated On : 22 May 2024 | 7:42 AM IST

Metropolis Healthcare revenue up 17%, targets industry-leading growth

In Q4, the business-to-consumers (B2C) revenues grew by approximately 20 per cent Y-o-Y, and revenues from the Mumbai market also saw 20 per cent growth

Metropolis Healthcare revenue up 17%, targets industry-leading growth
Updated On : 21 May 2024 | 8:24 PM IST